DK3319970T3 - Pyrido-oxazinonderivater som tnap-hæmmere - Google Patents
Pyrido-oxazinonderivater som tnap-hæmmere Download PDFInfo
- Publication number
- DK3319970T3 DK3319970T3 DK16775006T DK16775006T DK3319970T3 DK 3319970 T3 DK3319970 T3 DK 3319970T3 DK 16775006 T DK16775006 T DK 16775006T DK 16775006 T DK16775006 T DK 16775006T DK 3319970 T3 DK3319970 T3 DK 3319970T3
- Authority
- DK
- Denmark
- Prior art keywords
- oxazino
- pyrido
- derivatives
- tnap inhibitors
- tnap
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562190145P | 2015-07-08 | 2015-07-08 | |
PCT/US2016/041345 WO2017007943A1 (en) | 2015-07-08 | 2016-07-07 | Pyrido-oxazinone derivatives as tnap inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3319970T3 true DK3319970T3 (da) | 2019-12-02 |
Family
ID=57045381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16775006T DK3319970T3 (da) | 2015-07-08 | 2016-07-07 | Pyrido-oxazinonderivater som tnap-hæmmere |
Country Status (28)
Country | Link |
---|---|
US (3) | US9920068B2 (da) |
EP (1) | EP3319970B1 (da) |
JP (1) | JP6666928B2 (da) |
KR (1) | KR102590067B1 (da) |
CN (1) | CN107207527B (da) |
AU (1) | AU2016291163B2 (da) |
CA (1) | CA2962795C (da) |
CO (1) | CO2017003830A2 (da) |
CY (1) | CY1122477T1 (da) |
DK (1) | DK3319970T3 (da) |
ES (1) | ES2754480T3 (da) |
HK (1) | HK1253572A1 (da) |
HR (1) | HRP20192121T1 (da) |
HU (1) | HUE046994T2 (da) |
IL (1) | IL251005B (da) |
LT (1) | LT3319970T (da) |
MX (1) | MX2017003822A (da) |
MY (1) | MY185558A (da) |
PH (1) | PH12018500066A1 (da) |
PL (1) | PL3319970T3 (da) |
PT (1) | PT3319970T (da) |
RS (1) | RS59594B1 (da) |
RU (1) | RU2715704C2 (da) |
SG (1) | SG11201701378WA (da) |
SI (1) | SI3319970T1 (da) |
TW (1) | TWI702220B (da) |
WO (1) | WO2017007943A1 (da) |
ZA (1) | ZA201701783B (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110167946B (zh) * | 2016-12-23 | 2022-04-08 | 第一三共株式会社 | 具有tnap抑制活性的磺酰胺化合物 |
TW201829417A (zh) * | 2016-12-23 | 2018-08-16 | 日商第一三共股份有限公司 | 氧氮呯化合物 |
US11932600B2 (en) | 2018-10-23 | 2024-03-19 | Daiichi Sankyo Company Limited | Biaryl derivative |
CN114085911B (zh) * | 2022-01-19 | 2022-05-17 | 珠海圣美生物诊断技术有限公司 | 一种检测肿瘤细胞或肿瘤细胞碎片的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4810795A (en) | 1982-09-30 | 1989-03-07 | A. H. Robins Company, Incorporated | Certain 2,5 and 2,5,6-di- and tri-substituted nicotinic acid intermediates |
CA2352612A1 (en) | 1998-11-27 | 2000-06-08 | Hideo Fukui | Pharmaceuticals |
PE20011061A1 (es) * | 2000-02-01 | 2001-11-20 | Procter & Gamble | Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato |
JP2009500442A (ja) | 2005-07-09 | 2009-01-08 | アストラゼネカ アクチボラグ | 2型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての2−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物 |
EP2433496A1 (en) | 2007-05-08 | 2012-03-28 | Burnham Institute for Medical Research | Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification |
BR112014020773A2 (pt) * | 2012-02-22 | 2020-10-27 | Sanford-Burnham Medical Research Institute | compostos de sulfonamida e seus usos como inibidores tnap |
-
2016
- 2016-07-07 WO PCT/US2016/041345 patent/WO2017007943A1/en active Application Filing
- 2016-07-07 PT PT167750066T patent/PT3319970T/pt unknown
- 2016-07-07 AU AU2016291163A patent/AU2016291163B2/en active Active
- 2016-07-07 MX MX2017003822A patent/MX2017003822A/es active IP Right Grant
- 2016-07-07 CA CA2962795A patent/CA2962795C/en active Active
- 2016-07-07 EP EP16775006.6A patent/EP3319970B1/en active Active
- 2016-07-07 RU RU2017117179A patent/RU2715704C2/ru active
- 2016-07-07 SI SI201630466T patent/SI3319970T1/sl unknown
- 2016-07-07 SG SG11201701378WA patent/SG11201701378WA/en unknown
- 2016-07-07 HU HUE16775006A patent/HUE046994T2/hu unknown
- 2016-07-07 LT LT16775006T patent/LT3319970T/lt unknown
- 2016-07-07 PL PL16775006T patent/PL3319970T3/pl unknown
- 2016-07-07 CN CN201680006507.5A patent/CN107207527B/zh active Active
- 2016-07-07 DK DK16775006T patent/DK3319970T3/da active
- 2016-07-07 TW TW105121542A patent/TWI702220B/zh active
- 2016-07-07 MY MYPI2017700569A patent/MY185558A/en unknown
- 2016-07-07 US US15/314,887 patent/US9920068B2/en active Active
- 2016-07-07 JP JP2017556523A patent/JP6666928B2/ja active Active
- 2016-07-07 RS RS20191522A patent/RS59594B1/sr unknown
- 2016-07-07 KR KR1020177010518A patent/KR102590067B1/ko active IP Right Grant
- 2016-07-07 ES ES16775006T patent/ES2754480T3/es active Active
-
2017
- 2017-03-07 IL IL251005A patent/IL251005B/en active IP Right Grant
- 2017-03-13 ZA ZA2017/01783A patent/ZA201701783B/en unknown
- 2017-04-06 US US15/481,151 patent/US9879032B2/en active Active
- 2017-04-20 CO CONC2017/0003830A patent/CO2017003830A2/es unknown
-
2018
- 2018-01-05 PH PH12018500066A patent/PH12018500066A1/en unknown
- 2018-01-18 US US15/874,768 patent/US10221195B2/en active Active
- 2018-10-08 HK HK18112777.4A patent/HK1253572A1/zh unknown
-
2019
- 2019-11-27 CY CY20191101247T patent/CY1122477T1/el unknown
- 2019-11-27 HR HRP20192121TT patent/HRP20192121T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
DK3464271T3 (da) | Pyrazolderivater som plasma-kallikreininhibitorer | |
DK3277677T3 (da) | 1-cyano-pyrrolidinforbindelser som usp30-hæmmere | |
DK3377488T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
DK3302448T3 (da) | Erstattede heterocyclylafledninger som cdk-inhibitore | |
DK3298002T3 (da) | Heterocykliske amider som kinasehæmmere | |
DK3105218T3 (da) | Cyclopropylaminer som lsd1-inhibitorer | |
DK3105226T3 (da) | Cyclopropylaminer som lsd1-inhibitorer | |
DK3319956T3 (da) | Substituerede oxopyridinderivater | |
DK3313832T3 (da) | 3-tetrazolyl-benzen-1,2-disulfonamidderivater som metallo-beta- lactamase-hæmmere | |
DK3786162T3 (da) | Bipyrazolderivater som jak-inhibitorer | |
DK3442972T3 (da) | Bromdomænehæmmere | |
DK3204381T3 (da) | N-pyridinylacetamidderivater som wnt-signaleringsbanehæmmere | |
DK3094631T3 (da) | Pyrimidinyloxybenzenderivater som herbicider | |
BR112016030697A2 (pt) | inibidores da desmetilase-1 específica da lisina | |
DK3271349T3 (da) | Benzimidazolederivater som bromodomain-inhibitorer | |
DK3286177T3 (da) | Quinolinderivater som tam rtk-inhibitorer | |
DK3458460T3 (da) | Imidazoler som histondemethylase-inhibitorer | |
DK3288944T3 (da) | Imidazopyrazinoner som pde1-inhibitorer | |
DK3116475T3 (da) | Dopa-decarboxylasehæmmersammensætninger | |
DK3186242T3 (da) | Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere | |
DK3544981T3 (da) | Benzodiazoliumforbindelser som enac-inhibitorer | |
DK3341379T3 (da) | EZH2-hæmmere | |
DK3114120T3 (da) | Tetrazolon-substituerede dihydropyridinon-mgat2-hæmmere |